300347 泰格醫藥
按盤價 
49.850 -0.930 (-1.831%)
49.850 -0.930 (-1.831%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -2.043 | 4.266 | 1.943 | 9.972 | 10.643 |
| 總資產報酬率 ROA (%) | -1.469 | 3.114 | 1.389 | 7.089 | 7.840 |
| 投入資產回報率 ROIC (%) | -1.744 | 3.661 | 1.627 | 8.277 | 9.110 | 邊際利潤分析 |
| 銷售毛利率 (%) | 27.525 | 27.415 | 33.954 | 38.577 | 39.637 |
| 營業利潤率 (%) | -2.121 | 14.773 | 10.062 | 33.680 | 36.446 |
| 息稅前利潤/營業總收入 (%) | -1.023 | 16.144 | 10.639 | 32.235 | 34.257 |
| 淨利潤/營業總收入 (%) | -5.003 | 11.782 | 6.782 | 29.116 | 32.062 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | -447.132 | 51.849 | 149.455 | 73.534 | 74.609 |
| 價值變動淨收益/利潤總額(%) | 555.699 | 47.455 | -50.424 | 27.765 | 24.701 |
| 營業外收支淨額/利潤總額(%) | 1.953 | -0.618 | 0.006 | 0.064 | 0.115 | 償債能力分析 |
| 流動比率 (X) | 2.486 | 2.179 | 1.720 | 2.741 | 2.978 |
| 速動比率 (X) | 2.461 | 2.164 | 1.712 | 2.735 | 2.972 |
| 資產負債率 (%) | 17.214 | 14.466 | 16.067 | 17.611 | 17.363 |
| 帶息債務/全部投入資本 (%) | 14.460 | 9.931 | 13.094 | 14.353 | 13.711 |
| 股東權益/帶息債務 (%) | 576.303 | 879.094 | 644.373 | 578.707 | 604.915 |
| 股東權益/負債合計 (%) | 405.638 | 510.912 | 448.724 | 402.258 | 410.935 |
| 利息保障倍數 (X) | -0.897 | 11.042 | 18.455 | -21.973 | -15.350 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 66.451 | 72.853 | 71.433 | 55.786 | 46.665 |
| 存貨周轉天數 (天) | 3.588 | 2.666 | 2.285 | 1.810 | 1.191 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 28/08/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
